We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
Cap. Flow
-$238M
Cap. Flow %
-3.93%
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36

Top Buys

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$41.9M
2
GNRC icon
Generac Holdings
GNRC
+$40.9M
3
PCVX icon
Vaxcyte
PCVX
+$24.8M
4
TER icon
Teradyne
TER
+$24.8M
5
ULS icon
UL Solutions
ULS
+$21.1M

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$64.4M
2
GEV icon
GE Vernova
GEV
+$42.1M
3
INSP icon
Inspire Medical Systems
INSP
+$40.6M
4
RNAM
Avidity Biosciences
RNAM
+$37.8M
5
LAD icon
Lithia Motors
LAD
+$33.8M

Sector Composition

Rank Sector Weight
1 Healthcare 39.12%
2 Industrials 19.41%
3 Technology 15.63%
4 Energy 7.14%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NDAQ icon
26
Nasdaq
NDAQ
$55.7B
$60.2M 1%
711,839
+4,791
+0.7% +$429K
GNRC icon
27
Generac Holdings
GNRC
$11.4B
$59.9M 0.99%
306,838
+212,978
+227% +$40.9M
BBNX
28
Beta Bionics
BBNX
$896M
$59.6M 0.99%
5,945,488
+950,760
+19% +$14.1M
DHI icon
29
D.R. Horton
DHI
$41.1B
$59M 0.98%
430,871
+3,826
+0.9% +$578K
KLAC icon
30
KLA
KLAC
$236B
$57.8M 0.96%
396,390
-56,430
-12% -$8.26M
BLTE
31
Belite Bio
BLTE
$6.22B
$57M 0.94%
357,650
-25,441
-7% -$4.28M
LSCC icon
32
Lattice Semiconductor
LSCC
$16.8B
$56.6M 0.94%
611,138
-10,018
-2% -$898K
PLD icon
33
Prologis
PLD
$135B
$56.1M 0.93%
427,133
+6,299
+1% +$842K
TMDX icon
34
Transmedics
TMDX
$3.13B
$54.5M 0.9%
548,824
+557
+0.1% +$72.7K
DTM icon
35
DT Midstream
DTM
$13.5B
$54.1M 0.9%
401,951
+7,227
+2% +$943K
NI icon
36
NiSource
NI
$19.7B
$53.3M 0.88%
1,143,590
+10,370
+0.9% +$467K
KYMR icon
37
Kymera Therapeutics
KYMR
$9.87B
$52.2M 0.86%
626,925
+495
+0.1% +$39.2K
RBA icon
38
RB Global
RBA
$15.8B
$50.6M 0.84%
528,143
+548
+0.1% +$58.1K
WCN
39
Waste Connections
WCN
$41.6B
$50.3M 0.83%
309,927
-184
-0.1% -$30.7K
ORLY icon
40
O'Reilly Automotive
ORLY
$71.4B
$49.8M 0.82%
539,880
-1,987
-0.4% -$186K
PWR icon
41
Quanta Services
PWR
$92.2B
$49M 0.81%
89,386
+454
+0.5% +$234K
COLL icon
42
Collegium Pharmaceutical
COLL
$816M
$47.1M 0.78%
1,424,282
-451,957
-24% -$19.1M
APGE icon
43
Apogee Therapeutics
APGE
$10.2B
$46.9M 0.78%
557,423
+121,408
+28% +$8.82M
VMC icon
44
Vulcan Materials
VMC
$35.3B
$46.2M 0.76%
169,572
+205
+0.1% +$60.3K
NVDA icon
45
NVIDIA
NVDA
$5.41T
$44.7M 0.74%
259,419
+20,135
+8% +$3.69M
EGP icon
46
EastGroup Properties
EGP
$10.8B
$43.6M 0.72%
235,730
-428
-0.2% -$79.9K
IONS icon
47
Ionis Pharmaceuticals
IONS
$10.1B
$43.2M 0.71%
575,000
– –
STE icon
48
Steris
STE
$22.6B
$43M 0.71%
194,635
+4,152
+2% +$1.02M
PANW icon
49
Palo Alto Networks
PANW
$291B
$40.4M 0.67%
252,151
+106,260
+73% +$17.9M
LOW icon
50
Lowe's Companies
LOW
$116B
$40.2M 0.67%
170,635
+7
+0% +$1.83K
1
2
3 4 5

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.

  • Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
  • Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
  • Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
  • Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
  • Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
  • Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
  • Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.